EVOK Logo.jpg
Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
19 sept. 2024 14h20 HE | Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
EVOK Logo.jpg
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
09 sept. 2024 08h30 HE | Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
EVOK Logo.jpg
Evoke Pharma to Present at H.C. Wainwright’s 26th Annual Global Investment Conference
04 sept. 2024 09h20 HE | Evoke Pharma, Inc.
SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
EVOK Logo.jpg
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results
13 août 2024 08h00 HE | Evoke Pharma, Inc.
GIMOTI second quarter net product sales grew 47% quarter-over-quarter and 126% year-over-year, indicating an annual run-rate in excess of $10 million Achieved record-high prescription fills...
EVOK Logo.jpg
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month
08 août 2024 08h30 HE | Evoke Pharma, Inc.
Collaborating with advocacy groups to amplify gastroparesis awareness for millions of patients worldwide Call for action to improve health and access for patients SOLANA BEACH, Calif., Aug....
EVOK Logo.jpg
Evoke Pharma, Inc. Announces Reverse Stock Split
30 juil. 2024 08h30 HE | Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
EVOK Logo.jpg
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
17 juin 2024 08h30 HE | Evoke Pharma, Inc.
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA...
EVOK Logo.jpg
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
16 mai 2024 16h02 HE | Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
EVOK Logo.jpg
Evoke Pharma Reports First Quarter 2024 Financial Results
14 mai 2024 16h15 HE | Evoke Pharma, Inc.
114% year-over-year increase in net product sales70% prescriber growth in Q1 2024 compared to Q4 2023Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024 SOLANA BEACH, Calif.,...
EVOK Logo.jpg
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
17 avr. 2024 08h30 HE | Evoke Pharma, Inc.
SOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...